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As the critical care community enters the new millennium, it
will continue to encounter ethical challenges with regard to
allocation, application, and use of newly emerging
therapeutics. Critical Care Forum accepts this challenge
and, in the coming months, will feature regular articles on
ethical issues specific to the field.
The evidence found in medical literature suggests that during
the past 30 years we have learned a great deal about critical
illness and how to keep patients alive. Unfortunately, buoyed
by these successes, we have lagged behind in helping
patients and their families to decide how our therapeutic tools
should be used in the context of individual and societal goals,
values, and beliefs. For instance, our technological advances
have enabled us to maintain moribund patients in a state of
suspended animation for prolonged and sometimes indefinite
periods; however, just because we can, does that mean we
should? We have also not yet decided how to ensure that any
potential benefits are fairly and equitably accessible to the
greatest number of patients, if indeed the greatest number is
the best test of ethical use of our resources.
As critical care medicine continues to advance we will
develop more and more therapeutics – some of which will be
expensive to administer – that may be beneficial to patients.
In the face of limited health care budgets all over the world,
however, we need to talk more about how these advances
will affect the interests of the population as a whole;
otherwise we risk reaching a point a which marginal gains to
individuals threaten the welfare of the majority.
Dilemmas arise when one practices medicine and designs
research at the forefront of technology, for clinicians and
ethics review boards alike. Research and development of
novel therapeutics demand that investigators address the
ethics of their proposed methods when determining how
treatments should be used. Much of the research intensivists
perform depends on recruiting patients with similar spectra
and severities of illness. Researchers often struggle to design
trials within these constraints, and often depend on
multicentered trials in order to achieve sufficient statistical
power to detect differences in outcomes. However, the same
researchers are often frustrated by the seemingly variable
decisions made by research ethics boards. If a research
proposal is designed according to ethical standards, such as
those outlined in the Declaration of Helsinki, then why does
such variability exist? Should it exist? Is such variability
perhaps protective of research subjects? How can it be
avoided or overcome? Furthermore, what responsibility do
researchers and research ethics boards bear when the
interventional treatment being studied carries significant risks
for the subjects? Also, if a pharmaceutical company is
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involved in the design and/or funding of a project, then what
are the responsibilities and obligations of the investigator to
future subjects and to the research ethics board if adverse
events occur?
Unfortunately, little guidance exists to help, but these are only
some of the challenges we confront as we seek to expand
our knowledge in critical care. If we fail to respond to these
challenges, or fail to anticipate and/or respond to the ethical
issues and questions posed by research ethics boards, then
we risk failing to discover more novel therapeutics and to
explore how these may best be used to improve further the
survival and decrease the morbidity of our patients.
Until recently, few critical care training programs included
structured teaching in bioethics; of those that do, most quote
principlism (autonomy, beneficence, nonmaleficence and
justice) as the sole guiding light. However, as critical care
practitioners, we confront more ethical dilemmas (both in
clinical practice and research) than do our colleagues in
other fields. Often we are challenged either to facilitate
decision-making or to resolve conflicts between the health
care team and the patient/substitute decision-maker over
whether our life-sustaining tools should be used or we should
offer as yet experimental therapies in a last ditch attempt to
save a life. What costs to the patient who must undergo our
therapies; to the health care team, who must perform often
invasive, painful procedures when the chances of survival are
very poor; and to society are we all willing to accept?
Moreover, the acuity and severity of critical illness means,
more often than not, that we have little time to resolve these
ethical dilemmas. We must discard the notion that the skills
to approach and resolve ethical dilemmas are innate in all
intensivists, and instead strive to create and develop our
ability to think critically in bioethics so as to confront the
unique challenges that lie ahead.
In a perfect world there would be a perfect balance of supply
and demand between health care providers and the public; a
balance between the health care the public needs and that
which its want; and a balance between what health care
providers want to provide and what the public wants to be
able to access. This balance clearly does not exist, especially
in critical care. Largely due to the media, the general public is
aware that current technology is capable of indiscriminately
maintaining some vital bodily functions, but they may not
understand that this same technology does not always heal
the underlying disease. As intensivists, we must be able to
discuss these issues with as much facility as we do the
expensive magic bullets for systemic sepsis.
The future of critical care and how we get we get there
depends directly on our abilities to think critically through the
ethical challenges posed by the exciting therapeutics that
draw us to the field. We also need to think critically about our
ability to reconcile the interests of society, patients, their
families, and critical care practitioners, using logic and
reaching agreement on common goals. In the coming
months, Critical Care Forum will explore these and the other
ethical issues that so profoundly affect our ability to provide
meaningful health care through debates, case discussions,
roundtable discussions, and thought-provoking articles.
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